PL359999A1
6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyl) oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
Abstract
According to one aspect of the invention, there is provided a compound of formula (I) and solvates thereof. There are also provided compositions containing the compound, processes for preparing it, and its use in therapy.
Term
Term ended
Projected expiry passed 3 August 2021, 5.1 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
255 members in 41 offices
Priority claims12
| Document | Office | Kind | Date |
|---|---|---|---|
| 0019172 | United Kingdom | A | |
| 0019172 | United Kingdom | A | |
| 0108800 | United Kingdom | A | |
| 0108800 | United Kingdom | A | |
| 0103495 | United Kingdom | W | |
| 0103495 | United Kingdom | W | |
| 000019172 | – | – | – |
| 010108800 | – | – | – |
| 01GB0103495 | – | – | – |
| GB20000019172 | – | – | – |
| GB20010008800 | – | – | – |
| WO2001GB03495 | – | – | – |
Members255
| Document | Office | Kind | |
|---|---|---|---|
| GB0019172D0 | United Kingdom | D0 | |
| GB0108800D0 | United Kingdom | D0 | |
| CA2417825A1 | Canada | A1 | |
| CA2417826A1 | Canada | A1 | |
| CA2634715A1 | Canada | A1 | |
| DZ3468A1 | Algeria | A1 | |
| WO0212265A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO0212266A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU7576001A | Australia | A | |
| AU7649701A | Australia | A | |
| US2002165211A1 | United States of America | A1 | |
| US2002173496A1 | United States of America | A1 | |
| US2002177581A1 | United States of America | A1 | |
| NO20030549D0 | Norway | D0 | |
| NO20030549L | Norway | L | |
| NO20030550D0 | Norway | D0 | |
| US2003045512A1 | United States of America | A1 | |
| US6537983B1 | United States of America | B1 | |
| ECSP034470A | Ecuador | A | |
| NO20030550L | Norway | L | |
| KR20030028806A | Republic of Korea | A | |
| US2003073676A1 | United States of America | A1 | |
| EP1305329A1 | European Patent Office (EPO) | A1 | |
| EP1305330A1 | European Patent Office (EPO) | A1 | |
| CZ2003353A3 | Czechia | A3 | |
| US2003092690A1 | United States of America | A1 | |
| MXPA03001096A | Mexico | A | |
| MXPA03001097A | Mexico | A | |
| SK1422003A3 | Slovakia | A3 | |
| US2003109511A1 | United States of America | A1 | |
| BR0113042A | Brazil | A | |
| BR0113039A | Brazil | A | |
| IL154148D0 | Israel | D0 | |
| IL154175D0 | Israel | D0 | |
| US2003144257A1 | United States of America | A1 | |
| US2003153542A1 | United States of America | A1 | |
| WO03066024A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO03066026A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO03066032A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO03066033A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO03066036A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO03066656A1 | World Intellectual Property Organization (WIPO) | A1 | |
| TW200302831A | Taiwan Province of China | A | |
| EA200300082A1 | Eurasian Patent Organization (EAPO) | A1 | |
| CO5310534A1 | Colombia | A1 | |
| CO5310550A1 | Colombia | A1 | |
| AU2003205850A1 | Australia | A1 | |
| AU2003205855A1 | Australia | A1 | |
| AU2003207016A1 | Australia | A1 | |
| AU2003207019A1 | Australia | A1 | |
| AU2003244450A1 | Australia | A1 | |
| AU2003244506A1 | Australia | A1 | |
| KR20030071751A | Republic of Korea | A | |
| BG107518A | Bulgaria | A | |
| MA25899A1 | Morocco | A1 | |
| US2003199485A1 | United States of America | A1 | |
| AR032361A1 | Argentina | A1 | |
| AR032471A1 | Argentina | A1 | |
| HU0303084A2 | Hungary | A2 | |
| CN1468252A | China | A | |
| CN1468253A | China | A | |
| TW200400837A | Taiwan Province of China | A | |
| HU0303354A2 | Hungary | A2 | |
| WO2004009613A1 | World Intellectual Property Organization (WIPO) | A1 | |
| HK1056180A1 | Hong Kong, China | A1 | |
| HK1056181A1 | Hong Kong, China | A1 | |
| AU2003253354A1 | Australia | A1 | |
| US2004028615A1 | United States of America | A1 | |
| JP2004505989A | Japan | A | |
| JP2004505990A | Japan | A | |
| WO2004024745A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003266390A1 | Australia | A1 | |
| AU2003266390A8 | Australia | A8 | |
| ZA200300932B | South Africa | B | |
| US6750210B2 | United States of America | B2 | |
| US6759398B2 | United States of America | B2 | |
| OA12394A | African Intellectual Property Organization (OAPI) | A | |
| ZA200300929B | South Africa | B | |
| US6777399B2 | United States of America | B2 | |
| US6777400B2 | United States of America | B2 | |
| PL359917A1 | Poland | A1 | |
| PL359999A1This record | Poland | A1 | |
| US6787532B2 | United States of America | B2 | |
| EP1471884A1 | European Patent Office (EPO) | A1 | |
| EP1471895A1 | European Patent Office (EPO) | A1 | |
| EP1471896A1 | European Patent Office (EPO) | A1 | |
| EP1471900A1 | European Patent Office (EPO) | A1 | |
| EP1472272A1 | European Patent Office (EPO) | A1 | |
| US2004220156A1 | United States of America | A1 | |
| US2004220157A1 | United States of America | A1 | |
| US2004220162A1 | United States of America | A1 | |
| US2004224931A1 | United States of America | A1 | |
| US2004224932A1 | United States of America | A1 | |
| US2004224934A1 | United States of America | A1 | |
| US2004225139A1 | United States of America | A1 | |
| EP1478340A1 | European Patent Office (EPO) | A1 | |
| NZ523958A | New Zealand | A | |
| NZ523957A | New Zealand | A | |
| AR038348A1 | Argentina | A1 | |
| AR038686A1 | Argentina | A1 |
Showing 100 of 255
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Rectifications of patent specificationRECP | RECP | |
| Rectifications of patent specificationRECP | RECP |
Numbers
- Publication, DOCDB
- 359999
- Publication, EPODOC
- PL359999
- Application
- 1359999
- Application, DOCDB
- 35999901
- Application, EPODOC
- PL20010359999
Titles2
- English
- 6.ALPHA., 9.ALPHA.-DIFLUORO-17.ALPHA.-`(2-FURANYLCARBOXYL) OXY!-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXO-ANDROST-1,4,-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT
- Polish
- Ester S-fluorometylowy kwasu 6alfa, 9alfa-difluoro-17alfa-(2-furanylokarbokyl) oksy-11beta-hydroksy-16alfa-metylo-3-oksoandrosta-1,4,-dieno-17-karbotiowego jako środek przeciwzapalny
Classification
- CPC, 20
- C07J31/006
- C07J31/00
- A61P1/04
- A61P1/08
- A61P11/00
- A61P11/02
- A61P11/06
- A61P11/08
- A61P17/00
- A61P17/02
- A61P17/04
- A61P17/06
- A61P19/02
- A61P27/02
- A61P27/14
- A61P29/00
- A61P37/08
- A61P43/00
- A61P5/00
- A61P5/44
- IPC, 18
- A61K9 12
- A61K9 14
- A61K31 56
- A61K31 58
- A61K45 00
- A61K47 06
- A61K47 18
- A61K47 36
- A61P5 44
- A61P11 06
- A61P11 08
- A61P29 00
- A61P37 08
- A61P43 00
- C07J17 00
- C07J31 00
- C07J33 00
- C07J43 00